Pharma stocks snap 3-day losses; Lupin rises 2% after Jefferies reiterates 'Buy' call
Pharma stocks: Jefferies said that biosimilars segment is likely to be the next big growth engine for Lupin.
Pharma stocks: Jefferies said that biosimilars segment is likely to be the next big growth engine for Lupin.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
